Breaking News

BioMed X, Janssen Begin Autoimmunity and Drug Delivery Research

New research groups, PTA and TMI, aim to combat chronic inflammatory diseases and develop oral delivery of macromolar therapeutics.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

German independent research institute BioMed X has initiated two new research projects with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The collaboration aims to address two challenging new research areas.   The new research group PTA (Protective Tissue Factors in Autoimmune Diseases) is led by Mojca Frank Bertoncelj, MD, PhD, who is joining BioMed X from the University Hospital Zurich in Switzerland. Her research group will d...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters